Virax Biolabs Group Ltd, 2025-12-18
An SEC Form D private-offering notice from Lanarkshire, a $5,000,000 filer-stated offering target in Biotech. Filed 2025-12-18. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Nasdaq listed biotechnology company developing T cell based immune profiling diagnostics for viral diseases and post viral conditions such as Long COVID
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- InSitu Biologics, Inc, 2025-12-18, $8M, Oakdale, MN
- Paulex Bio Inc., 2025-12-18, $22.5M, La Jolla, CA
- KAZIA THERAPEUTICS LTD, 2025-12-18, $55.3M, Sydney Nsw
- Delfi Diagnostics, Inc., 2025-12-18, $60M, Palo Alto, CA
- Bio Usawa Inc., 2025-12-17, $1.7M, San Francisco, CA
- Mel-Mont Medical, Inc., 2025-12-17, $5M, Doral, FL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.